Related Experiment Videos
Continued occurrence of Accutane-exposed pregnancies
M A Honein1, L J Paulozzi, J D Erickson
1National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia 30341-3724, USA. mrh7@cdc.gov
Teratology
|August 22, 2001
Summary
Accutane use doubled in women, increasing birth defect risks. Advertising and poor contraception practices contribute to unintended pregnancies, highlighting the need for caution with this teratogenic acne medication.
Area of Science:
- Reproductive Health
- Dermatology
- Public Health
Background:
- Accutane (isotretinoin) is a potent teratogenic drug for severe acne.
- First-trimester exposure poses significant risks of major birth defects.
- Despite a Pregnancy Prevention Program, unintended pregnancies occur.
Observation:
- Accutane prescriptions for women of reproductive age have more than doubled.
- Direct-to-consumer advertising may increase exposure risks.
- Many exposed pregnancies involved inadequate or no contraception and insufficient adherence to prevention programs.
Findings:
- Approximately 2.5 per 1,000 reproductive-aged women were exposed in 1999.
- Half of interviewed women saw advertisements before treatment.
- Most women used no or inadequate contraception; few completed all pregnancy prevention program requirements.
Implications:
- Increased Accutane use, potentially driven by advertising, raises public health concerns.
- Physicians and patients require enhanced vigilance regarding teratogenic drug use.
- Improved adherence to contraception and pregnancy testing is crucial for preventing birth defects.